share_log

中國中藥:(I)修訂現有總採購協議之年度上限;及(II)更新有關該等新總協議之持續關連交易

TRAD CHI MED: (I) REVISION OF ANNUAL CAP IN RELATION TOTHE EXISTING MASTER PURCHASE AGREEMENT; AND(II) RENEWAL OF CONTINUING CONNECTED TRANSACTIONSIN RELATION TO THE NEW MASTER AGREEMENTS

Hong Kong Stock Exchange ·  Nov 11, 2022 22:26

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.